Two Case Reports on Faricimab and Aflibercept for Recalcitrant Radiation Maculopathy

Two detailed case reports describe the administration of faricimab and 8 mg aflibercept injections for radiation retinopathy following CyberKnife stereotactic radiotherapy. The 118.1 KB document, authored by figshare admin karger and last updated in April 2026, presents preliminary clinical observations on anatomical and visual outcomes. The data is shared under a CC-BY-4.0 license.

Use Cases

• Analyze treatment sequences and outcomes based on the detailed case presentations.
• Study the application of newer-generation anti-VEGF agents like faricimab based on the described clinical scenarios.
• Compare visual and anatomical improvement timelines based on the injection schedules and follow-up described.

Strengths

• Includes specific patient ages (25 and 35 years old) and detailed treatment timelines.
• Provides a clear comparison of two different drug regimens (faricimab and 8 mg aflibercept) for the same condition.
• Document is shared under a permissive CC-BY-4.0 license for reuse.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The 118.1 KB size indicates a very limited scope, containing only two case reports.

Provenance

Source

figshare admin karger

Collection Method

Clinical case documentation.

Freshness

Last updated 2026-04-21 07:55:09; freshness should be verified.